Sepsis – how big a problem is it?

Prof. Mervyn Singer

Click here to access Forum Lectures list

Your first lecture is FREE

Lecture overview

Sepsis is certainly a major cause of mortality and morbidity worldwide, but how common is it? Do we have any idea of true incidence and mortality? This talk will critically examine current epidemiology and ask the questions as to how many deaths are directly attributable, and how many are avoidable.

Learning Objectives:
By the end of this lecture, the attendee will be able to:

  1. Better understand the epidemiology of sepsis.
  2. Challenge the current dogma.
  3. Question the proportion of attributable and avoidable deaths.
  4. Appreciate that many patients do not have infection but rather sepsis mimics.
  5. Place management in context.

This lecture is equal to 1 CE Contact Hour, 1 CPD Point, and 1 AMA PRA Category 1 Credit


Additional CME Info

Release Date: February 1, 2020, Termination Date: January 31, 2023

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: EB Medicine designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit™ per lecture. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Commercial Support: This activity received no commercial support.

Earning Credit: In order to earn CME credit, the participant must take the pre-test, listen to the lecture, take the CME post-test, and complete the post-test evaluation.

Duration 1 hour(s).

Lecture speaker

Prof. Mervyn Singer
Chair of the International Sepsis Forum

Mervyn Singer is Professor of Intensive Care Medicine at University College London, UK. His primary research interests are sepsis and multi-organ failure, infection, shock and haemodynamic monitoring. Funding primarily comes from the Wellcome Trust, Medical Research Council, EU and NIHR.

He developed an oesophageal Doppler haemodynamic monitor now in widespread use worldwide and is currently trialling other novel monitors and therapeutic agents. His research spans from basic through translational to clinical and has led on several important multi-centre trials. He is the current Chair of the International Sepsis Forum and co-led the task force developing the ‘Sepsis-3’ international definitions (Singer JAMA 2016).

He has authored/edited multiple papers and textbooks, including the Oxford Handbook of Critical Care. He was the first UK Intensivist to be awarded Senior Investigator status by the National Institute for Health Research and to be invited to give plenary lectures at both the European and US Intensive Care Congresses.


CME Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.